Home › Funds › Prosight Management, LP › STTK

Prosight Management, LP position in STTK

SHATTUCK LABS INC · Health Care

Prosight Management, LP reported holding 7,648,094 shares of STTK (SHATTUCK LABS INC) in its Q3 2026 13F filing — a position valued at US$52.2M, representing 10.12% of its reported portfolio and ranking #2 among its reported holdings. Prosight Management, LP has disclosed STTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.65M sh
Reported value held$52.16M
Portfolio Weight10.12%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's STTK position evolved

Prosight Management, LP first disclosed a stake in STTK in Q3 2023 at 2,123,000 shares (US$3.2M). The position peaked in Q3 2026 at 7,648,094 shares, worth US$52.2M. Across 13 filings, Prosight Management, LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,648,094 shares valued at US$52.2M — an increase of 1,690,217 shares quarter over quarter.. Notable position changes include a 98% trim in Q3 2024 (shares fell 65% over the following quarter), a 7549% increase in Q4 2024 (shares fell 21% over the following quarter), a 110% increase in Q1 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.12M $3.23M New
Q4 2023 2.78M $19.84M Add
Q1 2024 3.73M $33.30M Add
Q2 2024 4.67M $18.03M Add
Q3 2024 86.80K $302.93K Reduce
Q4 2024 6.64M $8.03M Add
Q1 2025 6.64M $6.31M Hold
Q2 2025 6.64M $5.26M Hold
Q3 2025 5.45M $13.03M Reduce
Q4 2025 2.38M $8.69M Reduce
Q1 2026 5.00M $32.18M Add
Q2 2026 5.96M $41.35M Add
Q3 2026 7.65M $52.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STTK and 13F data

STTK (SHATTUCK LABS INC) is a Health Care company. 55 other funds we track also report a position in STTK — the largest reported positions include Redmile Group, LLC (US$47.8M), ORBIMED ADVISORS LLC (US$43.8M), Frazier Life Sciences Management, L.P. (US$26.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STTK

All STTK fund holders →

FAQ

How long has Prosight Management, LP held STTK?

Prosight Management, LP has disclosed STTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Prosight Management, LP's current position in STTK?

As of Q3 2026, Prosight Management, LP holds 7.65M shares of STTK (SHATTUCK LABS INC), valued at $52.16M, representing 10.12% of its reported portfolio and ranking #2.

Has Prosight Management, LP been buying or selling STTK?

In the latest 13F filing (Q3 2026), Prosight Management, LP increased its position in STTK. The position peaked in Q3 2026 at 7.65M shares.

Which other funds hold STTK?

Other major institutional holders of STTK include Redmile Group, LLC, ORBIMED ADVISORS LLC, Frazier Life Sciences Management, L.P., among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.